+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mechanisms of methotrexate resistance in acute leukemia. Decreased transport and polyglutamylation



Mechanisms of methotrexate resistance in acute leukemia. Decreased transport and polyglutamylation



Advances in Experimental Medicine and Biology 457: 543-550



Drug resistance limits the effectiveness of methotrexate (MTX) for the treatment of acute leukemia. An increased understanding of the pathways involved in folate metabolism has allowed investigations of the mechanisms of resistance observed in leukemic blasts obtained from patients. Acute lymphocytic leukemia (ALL) was studied for mechanisms of acquired MTX resistance. MTX transport in 27 patients with untreated ALL and 31 patients with relapsed ALL was measured using a previously described competitive displacement assay. Only 13% of the untreated patients were considered to have impaired MTX transport whereas over 70% of the relapsed patients had evidence of impaired MTX transport. Northern analyses and quantitative RT-PCR for the reduced folate carrier (RFC) were performed on the RNA available from the leukemic blasts of 24 patients in whom MTX transport had been measured. Six of 9 samples with impaired MTX transport had decreased RFC expression (one had no detectable RFC expression), while three had no decrease in RFC expression. Acute myelocytic leukemia (AML) was studied to determine the basis of the decreased MTX polyglutamylation. Enzyme kinetics of the enzyme folylpolyglutamate synthetase (FPGS) were studied, demonstrating FPGS in the myeloid cell lines and patient samples had a higher K(m) for MTX as a substrate than lymphoid cells. Measuring gamma-glutamyl hydrolase enzyme activity allowed a more accurate prediction of steady state levels of MTX polyglutamates. A knowledge of the mechanisms of MTX resistance that occur in leukemic blasts obtained from patients may allow the development of therapeutic strategies to circumvent resistance.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046645375

Download citation: RISBibTeXText

PMID: 10500832


Related references

Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease. Leukemia 7(7): 1000-1004, 1993

Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. Blood 89(3): 1013-1018, 1997

Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia. Leukemia 11(6): 886-889, 1997

Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia. Leukemia 11(6): 886-889, 1997

Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Research 61(19): 7225-7232, 2001

Transport of methotrexate and folates by multidrug resistance protein 3 and MRP1 Effect of polyglutamylation on MTX transport. Cancer Research 61(19): 7225-7232, October 1, 2001

Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug. Cancer Research 49(19): 5275-5280, 1989

Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia. Blood 85(2): 500-509, 1995

Transport of methotrexate and E217betaG by ABCG2 Effects of variation at amino acid position 482 and polyglutamylation on methotrexate transport. Proceedings of the American Association for Cancer Research Annual Meeting 44: 113, 2003

The possible role of methotrexate mtx polyglutamylation in predicting outcome of treatment of adult vs children with acute lymphoblastic leukemia all. Proceedings of the American Association for Cancer Research Annual Meeting 32: 194, 1991

Defective polyglutamylation caused by an altered folylpolyglutamate synthetase as a mechanism of methotrexate resistance in human leukemia cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 30: 473, 1989

Impaired polyglutamylation as a mechanism of resistance to methotrexate mtx in human leukemia ccrf cem cells exposed to high dose short term exposures to this drug. Proceedings of the American Association for Cancer Research Annual Meeting 28: 285, 1987

Impaired methotrexate polyglutamylation in a human leukemia cell line resistant to short-term, high-dose methotrexate. Pharmacological Research Communications 20(5): 445-446, 1988

Decreased polyglutamylation of methotrexate in human soft tissue sarcomas. Proceedings of the American Association for Cancer Research Annual Meeting 31: 342, 1990

Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia. Blood 80(5): 1158-1162, 1992